The reaction to Target Corp.'s first-quarter earnings report on Wednesday is ... Target is hardly alone in being stuck in this paradox. Walmart Inc. saw its stock tumble …
Target Corp. (TGT) posted weaker-than-expected first quarter earnings and slowing comparable store sales growth, but held to its full year outlook amid increasing …
Shares of Target (NYSE: TGT) are off more than 4 percent in premarket trading on the news. It's an echo of sorts to last quarter, when the stock sank sharply as …
MKM Partners is bullish about Target Corp. first-quarter earnings ... See: Home …
Target's (TGT) online sales surged 28% from a year ago. But subpar earnings sent the stock down 5% in early trading Wednesday. Target, like many other …
The stock cleared multi-year resistance near $7.00 in 1996 and took off in a strong trend advance, topping out at $38 in 1999 and dropping into a trading range that …
Target Corp. (TGT) reported quarterly adjusted profit of $1.32 a ... Target held to …
Tesaro's first drug to win approval from the Food and Drug Administration was Varubi, for chemotherapy-induced nausea and vomiting. However, the drug that's …